Efficacy and Safety of Ibrutinib in Indian Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: Cases from a Named Patient Program.
| Author | |
|---|---|
| Abstract | :
This named patient program evaluated the safety and efficacy of ibrutinib, a selective inhibitor of Bruton's tyrosine kinase in Indian patients with relapsed/refractory chronic lymphocytic leukemia (CLL, with/without chromosome 17 deletion [del17p]) and mantle cell lymphoma (MCL). |
| Year of Publication | :
1969
|
| Journal | :
Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology
|
| Volume | :
38
|
| Issue | :
4
|
| Number of Pages | :
508-515
|
| Date Published | :
1969
|
| ISSN Number | :
0971-5851
|
| DOI | :
10.4103/ijmpo.ijmpo_43_17
|
| Short Title | :
Indian J Med Paediatr Oncol
|
| Download citation |